These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9208384

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
    Bhattacharya SK, Chakrabarti A, Chatterjee SS.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():22-9. PubMed ID: 9684944
    [Abstract] [Full Text] [Related]

  • 45. Inhibition of MAO by fractions and constituents of hypericum extract.
    Bladt S, Wagner H.
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S57-9. PubMed ID: 7857511
    [Abstract] [Full Text] [Related]

  • 46. Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers.
    Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A.
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S44-6. PubMed ID: 7857508
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Second thoughts about safety of St John's wort.
    Ernst E.
    Lancet; 1999 Dec 11; 354(9195):2014-6. PubMed ID: 10636361
    [No Abstract] [Full Text] [Related]

  • 49. [Saint John's Wort as an antidepressant].
    Schulte PF.
    Ned Tijdschr Geneeskd; 2000 Sep 16; 144(38):1820-5. PubMed ID: 11020834
    [Abstract] [Full Text] [Related]

  • 50. Commentary: has hypericum found its place in antidepressant treatment?
    Linde K, Berner M.
    BMJ; 1999 Dec 11; 319(7224):1539. PubMed ID: 10651472
    [No Abstract] [Full Text] [Related]

  • 51. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU, Schürer M, Bässler D, Weiser D.
    Arzneimittelforschung; 2005 Dec 11; 55(1):15-22. PubMed ID: 15727160
    [Abstract] [Full Text] [Related]

  • 52. Pharmacodynamic effects of St. John's Wort on rat intracerebral field potentials.
    Dimpfel W, Hofmann R.
    Eur J Med Res; 1995 Dec 18; 1(3):157-67. PubMed ID: 9389678
    [Abstract] [Full Text] [Related]

  • 53. Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors.
    Perovic S, Müller WE.
    Arzneimittelforschung; 1995 Nov 18; 45(11):1145-8. PubMed ID: 8929227
    [Abstract] [Full Text] [Related]

  • 54. [The administration of St. John's wort (Hypericum perforatum) in the treatment of depression].
    Koszewska I.
    Psychiatr Pol; 2001 Nov 18; 35(2):199-210. PubMed ID: 11490885
    [Abstract] [Full Text] [Related]

  • 55. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
    Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I.
    J Geriatr Psychiatry Neurol; 1994 Oct 18; 7 Suppl 1():S47-53. PubMed ID: 7857509
    [Abstract] [Full Text] [Related]

  • 56. Does St. John's wort have an effect on autonomic responses of cutaneous circulation?
    Mueck-Weymann M, Tritt K, Moesler T, Rechlin T, Joraschky P.
    Microvasc Res; 1997 Nov 18; 54(3):270-2. PubMed ID: 9441898
    [No Abstract] [Full Text] [Related]

  • 57. [Clinical efficacy and tolerance of the hypericum special extract LI 160 in depressive disorders--a drug monitoring study].
    Holsboer-Trachsler E, Vanoni C.
    Praxis (Bern 1994); 1999 Sep 09; 88(37):1475-80. PubMed ID: 10522458
    [Abstract] [Full Text] [Related]

  • 58. [Do phytogenic drugs offer a savings potential? Pharmacoeconomics of plant antidepressives].
    Schulz V.
    Pharm Unserer Zeit; 2003 Sep 09; 32(3):248-52. PubMed ID: 12784546
    [No Abstract] [Full Text] [Related]

  • 59. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
    Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C.
    Pharmacopsychiatry; 1998 Jun 09; 31 Suppl 1():16-21. PubMed ID: 9684943
    [Abstract] [Full Text] [Related]

  • 60. Central action of hyperici herba cum flore extractum siccum in freely moving rats.
    Dimpfel W, Schombert L.
    Eur J Med Res; 1997 Nov 28; 2(11):491-6. PubMed ID: 9385121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.